The impact of fibrinolytic therapy for ST-segment-elevation acute myocardial infarction

被引：14
|
作者：
Van De Werf, F. J. [1 ]
Topol, E. J. [2 ]
Sobel, B. E. [3 ]
机构：
[1] Univ Hosp Leuven, Dept Cardiol, B-3000 Louvain, Belgium
[2] Scripps Res Inst, Dept Cardiovasc Med, La Jolla, CA 92037 USA
[3] Univ Vermont, Cardiovasc Res Inst, Colchester, VT USA
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2009年 / 7卷 / 01期
关键词：
acute myocardial infarction; fibrinolysis; primary PCI; tissue-plasminogen activator; reperfusion therapy; TISSUE PLASMINOGEN-ACTIVATOR; EARLY INTRAVENOUS HEPARIN; THROMBOLYTIC THERAPY; UNFRACTIONATED HEPARIN; CORONARY THROMBOLYSIS; PRIMARY ANGIOPLASTY; PREHOSPITAL THROMBOLYSIS; ALTEPLASE THROMBOLYSIS; ENOXAPARIN; TIME;
D O I：
10.1111/j.1538-7836.2008.03195.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
As privileged witnesses of the initiation and widespread use of reperfusion therapy the authors review the history of fibrinolytic therapy and of tissue-plasminogen activator (t-PA) more particularly and the current indications for its use in the era of mechanical reperfusion.
引用
收藏
页码：14 / 20
页数：7
相关论文
共 50 条
12345